Drug Profile
Dexrabeprazole
Alternative Names: Dexpure; Emrab; R(+)-RabeprazoleLatest Information Update: 16 Jan 2022
Price :
$50
*
At a glance
- Originator Emcure Pharmaceuticals
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Antiulcers; Gastric antisecretories; Small molecules
- Mechanism of Action Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Gastro-oesophageal reflux; Peptic ulcer
Most Recent Events
- 30 Sep 2007 Launched for Peptic ulcer and Gastro-oesophageal reflux in India (Parenteral)
- 30 Sep 2007 Launched for Peptic ulcer and Gastro-oesophageal reflux in India (PO)
- 05 Dec 2006 Phase-III clinical trials in Gastro-oesophageal reflux in India (PO)